Harry Glorikian

Directeur/Membre du Conseil chez STAGEZERO LIFE SCIENCES LTD.

Profil

Harry A. Glorikian is the founder of X-Cell Laboratories, founded in 1993.
Mr. Glorikian is the founder of Scientia Advisors LLC, founded in 2004, and served as Managing Partner from 2004 to 2014.
Mr. Glorikian was the founder of Drawbridge Health, Inc., founded in 2015, and served as Advisory Board Member from 2015 to 2020.
Current jobs include Director at StageZero Life Sciences Ltd. since 2008, Advisory Board member at Northeastern University since 2022, Member of Industry Advisory Committee at Beth Israel Deaconess Medical Center, Inc. since 2020, and General Partner at Scientia Ventures LLC since 2016.
Former jobs include Chief Executive Officer & Director at Drumroll Health, Inc., Director at Interpace Biosciences, Inc. in 2016, Board Of Directors at Biocartis Group NV from 2018 to 2020, Strategic Advisory Board Member at CEPHEID from 2014 to 2016, Member & Board of Advisors at Cibus Corp.
from 2012 to 2017, Advisory Board at Evidation Health, Inc. from 2015 to 2018, Member & Biomedical Advisory Board at The Charles Stark Draper Laboratory, Inc. from 2006 to 2015, Head-Global Sales at BioLegend CNS, Inc. from 1994 to 1997, and Senior Advisor at Precision Medicine Group LLC in 2014.
Education includes an MBA from Boston University and undergraduate studies at San Francisco State University.

Postes actifs de Harry Glorikian

Sociétés	Poste	Début
STAGEZERO LIFE SCIENCES LTD.	Directeur/Membre du Conseil	01/07/2008
Beth Israel Deaconess Medical Center, Inc.	Consultant / Advisor	01/09/2020
Northeastern University	Consultant / Advisor	01/07/2022
Scientia Ventures LLC	Private Equity Investor	01/12/2016

Anciens postes connus de Harry Glorikian

Sociétés	Poste	Fin
Drawbridge Health, Inc.	Fondateur	01/05/2020
BIOCARTIS GROUP NV	Directeur/Membre du Conseil	01/05/2020
Evidation Health, Inc.	Consultant / Advisor	01/01/2018
CALYXT, INC.	Consultant / Advisor	01/01/2017
CEPHEID	Consultant / Advisor	01/11/2016